Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study

References

• Cebolla A, Navarrete J, González-Moret R, et al. Effectiveness of a blended internet-based mindfulness intervention in inflammatory bowel disease patients: a mixed-methods non-randomized controlled trial. Mindfulness. 2021;12(11):1–8. doi: 10.1007/s12671-021-01741-2.
   PubMed Web of Science ®Google Scholar
• González-Moret R, Cebolla A, Cortés X, et al. The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial. Sci Rep. 2020;10(1):6071. doi: 10.1038/s41598-020-63168-4.
   PubMed Web of Science ®Google Scholar
• Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149(5):1275–1285.e2. doi: 10.1053/J.GASTRO.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Dai C, Jiang M, Sun MJ. Fecal markers in the management of inflammatory bowel disease. Postgrad Med. 2018;130(7):597–606. doi: 10.1080/00325481.2018.1503919.
   PubMed Web of Science ®Google Scholar
• Lężyk-Ciemniak E, Tworkiewicz M, Wilczyńska D, et al. Usefulness of testing for fecal calprotectin in pediatric gastroenterology clinical practice. Med Princ Pract. 2021;30(4):311–319. doi: 10.1159/000512631.
   PubMed Web of Science ®Google Scholar
• Knisely MR, Conley YP, Szigethy E. Cytokine genetic variants and health-related quality of life in crohn’s disease: an exploratory study. Biol Res Nurs. 2019;21(5):544–551. doi: 10.1177/1099800419860906.
   PubMed Web of Science ®Google Scholar
• Weaver KR, Melkus GD, Fletcher J, et al. Perceived stress, its physiological correlates, and quality of life in patients with irritable bowel syndrome. Biol Res Nurs. 2018;20(3):312–320. doi: 10.1177/1099800418756733.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Capristo E, Stefanini GF, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997;32(10):1013–1021. doi: 10.3109/00365529709011218.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Graff LA, Wilding H, et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-Part I. Inflamm Bowel Dis. 2018;24(4):742–751. doi: 10.1093/ibd/izx100.
   PubMed Web of Science ®Google Scholar
• Wong JJ, Sceats L, Dehghan M, et al. Depression and health care use in patients with inflammatory bowel disease. J Crohns Colitis. 2019;13(1):19–26. doi: 10.1093/ecco-jcc/jjy145.
   PubMed Web of Science ®Google Scholar
• Sarid O, Slonim-Nevo V, Schwartz D, et al. Differing relationship of psycho-social variables with active ulcerative colitis or crohn’s disease. Int J Behav Med. 2018;25(3):341–350. doi: 10.1007/s12529-018-9712-5.
   PubMed Web of Science ®Google Scholar
• Byrne G, Rosenfeld G, Leung Y, et al. Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017;2017. doi: 10.1155/2017/6496727.
   PubMed Web of Science ®Google Scholar
• Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease:a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105–1118. doi: 10.1002/ibd.20873.
   PubMed Web of Science ®Google Scholar
• Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80. doi: 10.1016/j.jpsychores.2016.06.001.
   PubMed Web of Science ®Google Scholar
• Rochelle TL, Fidler H. The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and crohn’s disease. J Health Psychol. 2012;18(7):972–983. doi: 10.1177/1359105312459094.
   PubMed Web of Science ®Google Scholar
• Trindade IA, Ferreira C, Pinto-Gouveia J. Inflammatory bowel disease: the harmful mechanism of experiential avoidance for patients’ quality of life. J Health Psychol. 2015;21(12):2882–2892. doi: 10.1177/1359105315587142.
   PubMed Web of Science ®Google Scholar
• Regev S, Odes S, Slonim-Nevo V, et al. Differential relationships of somatization, depression, and anxiety to severity of crohn’s disease. J Health Psychol. 2020;26(13):2390–2401. doi: 10.1177/1359105320909879.
   Google Scholar
• Navarrete J, González-Moret R, Cortés X, et al. Dispositional mindfulness and inflammatory bowel disease: mindful awareness mediates the relation between severity and quality of life, stress, and fatigue. Mindfulness. 2021;12(6):1524–1533. doi: 10.1007/s12671-021-01620-w.
   Web of Science ®Google Scholar
• Albar WF, Russell EW, Koren G, et al. Human hair cortisol analysis: comparison of the internationally-reported ELISA methods. Clin Invest Med. 2013;36(6):E312–6. doi: 10.25011/cim.v36i6.20629.
   PubMed Web of Science ®Google Scholar
• Masachs M, Casellas F, Malagelada JR. [Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)]. Rev Esp Enferm Dig. 2007;99(9):511–519. doi: 10.4321/S1130-01082007000900006.
   PubMed Web of Science ®Google Scholar
• Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a spanish population. Gen Hosp Psychiatry. 2003;25(4):277–283. doi: 10.1016/S0163-8343(03)00043-4.
   PubMed Web of Science ®Google Scholar
• Hopkins AG, Marshall SW, Batterham AM, et al. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3–13. doi: 10.1249/MSS.0b013e31818cb278.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119(1):15–22. doi: 10.1053/gast.2000.8523.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55(3):426–431. doi: 10.1136/gut.2005.069476.
   PubMed Web of Science ®Google Scholar
• Beaufils F, Mas E, Mittaine M, et al. Increased fecal calprotectin is associated with worse gastrointestinal symptoms and quality of life scores in children with cystic fibrosis. J Clin Med. 2020;9(12):4080. doi: 10.3390/JCM9124080.
   PubMed Web of Science ®Google Scholar
• Mavroudis G, Simren M, Jonefjäll B, et al. Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease. Therap Adv Gastroenterol. 2019;12:1756284819827689. doi: 10.1177/1756284819827689.
   Web of Science ®Google Scholar
• Naftali TI, Bar-Lev Schleider L, Scklerovsky Benjaminov F, et al. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial. PLoS One. 2021;16(2):e0246871. doi: 10.1371/journal.pone.0246871.
   PubMed Web of Science ®Google Scholar
• Kantidakis JD, Moulding R, Knowles SR. Psychological mediators of psychological distress and quality of life in inflammatory bowel disease. J Psychosom Res. 2021;149:110596. doi: 10.1016/J.JPSYCHORES.2021.110596.
   PubMed Web of Science ®Google Scholar
• Barberio B, Zamani M, Black CJ, et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370. doi: 10.1016/S2468-1253(21)00014-5.
   PubMed Web of Science ®Google Scholar
• Fairbrass KM, Lovatt J, Barberio B, et al. Bidirectional brain – gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut. 2022;71(9):1773–1780. doi: 10.1136/gutjnl-2021-325985.
   PubMedGoogle Scholar
• Fairbrass KM, Gracie DJ, Ford AC. Relative contribution of disease activity and psychological health to prognosis of inflammatory bowel disease during 6.5 years of longitudinal follow-Up. Gastroenterology. 2022;163(1):190–203.e5. doi: 10.1053/j.gastro.2022.03.014.
   PubMed Web of Science ®Google Scholar
• Chan W, Shim HH, Lim MS, et al. Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Dig Liver Dis. 2017;49(12):1314–1319. doi: 10.1016/J.DLD.2017.08.020.
   PubMedGoogle Scholar
• Renna ME, O’Toole MS, Spaeth PE, et al. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: a systematic review and meta-analysis. Depress Anxiety. 2018;35(11):1081–1094. doi: 10.1002/da.22790.
   PubMed Web of Science ®Google Scholar
• Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008;14(9):1273–1280. doi: 10.1002/ibd.20462.
   PubMed Web of Science ®Google Scholar
• Moser G. Depresión y ansiedad en la enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2009;32(2):9–12. doi: 10.1016/S0210-5705(09)72599-3.
   PubMedGoogle Scholar
• Bennebroek Evertsz F, Sprangers MAG, Sitnikova K, et al. Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: a multicenter randomized controlled trial. J Consult Clin Psychol. 2017;85(9):918–925. doi: 10.1037/CCP0000227.
   PubMed Web of Science ®Google Scholar
• Ballesio A, Zagaria A, Vacca M, et al. Comparative efficacy of psychological interventions on immune biomarkers: a systematic review and network meta-analysis (NMA). Brain Behav Immun. 2023;111:424–435. doi: 10.1016/j.bbi.2023.05.006.
   PubMed Web of Science ®Google Scholar
• O’Connor DB, Thayer JF, Vedhara K. Stress and health: a review of psychobiological processes. Annu Rev Psychol. 2021;72(1):663–688. doi: 10.1146/annurev-psych-062520-122331.
   PubMedGoogle Scholar
• Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815. doi: 10.1037/a0035302.
   PubMed Web of Science ®Google Scholar
• Günther C, Rothhammer V, Karow M, et al. The gut-brain axis in inflammatory bowel disease – current and future perspectives. Int J Mol Sci. 2021;22(16):8870. doi: 10.3390/ijms22168870.
   PubMed Web of Science ®Google Scholar
• Narula N, Pinto-Sanchez MI, Calo NC, et al. Anxiety but not depression predicts poor outcomes in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(7):1255–1261. doi: 10.1093/ibd/izy385.
   PubMed Web of Science ®Google Scholar
• Seaton N, Hudson J, Harding S, et al. Do interventions for mood improve inflammatory biomarkers in inflammatory bowel disease? a systematic review and meta-analysis. eBioMedicine. 2024;100:104910. doi: 10.1016/j.ebiom.2023.104910.
   PubMed Web of Science ®Google Scholar
• Geiss T, Schaefert RM, Berens S, et al. Risk of depression in patients with inflammatory bowel disease. J Dig Dis. 2018;19(8):456–467. doi: 10.1111/1751-2980.12644.
   PubMed Web of Science ®Google Scholar
• Iordache MM, Tocia C, Aschie M, et al. Intestinal permeability and depression in patients with inflammatory bowel disease. J Clin Med. 2022;11(17):5121. doi: 10.3390/jcm11175121.
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Wahed M, Mawdsley JE, et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012;18(12):2301–2309. doi: 10.1002/ibd.22916.
   PubMed Web of Science ®Google Scholar
• Mules TC, Swaminathan A, Hirschfeld E, et al. The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease – results from the stress, anxiety and depression with disease activity (SADD) study. Aliment Pharmacol Ther. 2022;55(2):201–211. doi: 10.1111/apt.16616.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Ford AC. Defining the relationship between depression and disease activity in IBD using clinical disease activity indices: merit or misnomer? Am J Gastroenterol. 2018;113(5):773–774. doi: 10.1038/s41395-018-0014-y.
   PubMed Web of Science ®Google Scholar